MONTREAL, Jan. 26 /CNW/ - Aptilon Corporation ("Aptilon" or the
"Corporation") (TSX-V: APZ), a leader in providing pharmaceutical companies
with online sales channels to physicians, today announced that Wayne Musial
has joined the company as Senior Vice President, Sales.
Musial has primarily assumed responsibility for sales operations, account
management, and client support for the Company's full line of products and
services that enable pharmaceutical marketers to create highly cost-effective
online sales channels to their target audiences of physicians and health care
practitioners. In this newly created role, he will be responsible for
Aptilon's pharmaceutical clients as well as its partners including alliances
with digital advertising agencies, pharmaceutical marketing companies, and CLM
Musial joined Aptilon from Triple I, a MediMedia company, where he served
as Executive Vice-president of Sales & Client Services working with leading US
pharmaceutical companies on physician promotion programs across the gamut of
personal and electronic media. He previously served at Vice-president of Sales
and Customer Service at Synavant, an IMS Health company, where he developed
consultative solutions for clients. With over 20 years of experience in sales
force technology and marketing, Musial has repeatedly introduced innovative
solutions for the pharmaceutical industry.
"Wayne's experience in helping companies optimize their promotional
approaches to target audiences in this very challenging environment will be a
key ingredient in Aptilon's ability to meet the needs of its growing customer
base," said President and Founder, Denis Martineau. "Wayne has a proven track
record of delivering double digit growth while building effective client
relationships. We are extremely pleased to add a person as respected in the
pharmaceutical industry to our leadership team."
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech and medical device companies to
effectively reach and interact with more than 450,000 US physicians via the
Internet through its innovative AxcelRx(SM) Live video detailing platform
which hosts promotional, peer selling and other sales and marketing programs.
Top ten US pharmaceutical companies have adopted Aptilon's AxcelRx(SM)
solution to reach leading physicians. Aptilon provides the infrastructure
necessary for pharmaceutical companies to build physician awareness,
understanding, and product preference during all stages of a product's life
cycle, from pre-launch education through end stage support. For more
information, visit www.aptilon.com.
AxcelRx(SM) and ReachNet(SM) are service marks of Aptilon Corporation.
This news release contains forward-looking information. These statements
relate to future events or future performance and reflect management's current
expectations and assumptions. Such forward-looking statements reflect
management's current beliefs and are based on information currently available
to management of Aptilon. A number of factors could cause actual events,
performance or results to differ materially from the events performance and
results discussed in the forward-looking statements. These forward-looking
statements are made as of the date hereof and Aptilon does not assume any
obligation to update or revise them to reflect new events or circumstances.
For further information:
For further information: For U.S. Media: Mark Gleason, Aptilon
Corporation, (847) 331-8628, email@example.com; For Canadian Media: Jeremy
Mackenzie-Lee, The Equicom Group, (514) 844-6054,